We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
3851
DELISTED
Verona Pharma
VRNA
$16.9K ﹤0.01%
1,166
+466
+67% +$6.8K
VANI icon
3852
Vivani Medical
VANI
$120M
$16.9K ﹤0.01%
13,379
+12,390
+1,253% +$21.2K
GOSS icon
3853
Gossamer Bio
GOSS
$88.9M
$16.8K ﹤0.01%
18,696
+1,398
+8% +$1.05K
VUG icon
3854
Vanguard Morningstar Growth ETF
VUG
$228B
$16.8K ﹤0.01%
270
+78
+41% +$4.55K
XPEV icon
3855
XPeng
XPEV
$11.4B
$16.8K ﹤0.01%
2,292
-69,589
-97% -$549K
FNGR icon
3856
FingerMotion
FNGR
$17.8M
$16.8K ﹤0.01%
6,587
-6,256
-49% -$19K
INDY icon
3857
iShares S&P India Nifty 50 Index Fund
INDY
$565M
$16.7K ﹤0.01%
+311
New +$15.9K
NXL icon
3858
Nexalin Technology
NXL
$7.88M
$16.7K ﹤0.01%
9,870
+791
+9% +$1.16K
DFLI icon
3859
Dragonfly Energy
DFLI
$18.5M
$16.7K ﹤0.01%
219
+18
+9% +$1.4K
PHUN icon
3860
Phunware
PHUN
$43.1M
$16.7K ﹤0.01%
3,036
-1,452
-32% -$9.55K
WAY
3861
Waystar Holding Corp
WAY
$4.66B
$16.7K ﹤0.01%
+775
New +$16.8K
GRTS
3862
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$16.6K ﹤0.01%
26,914
+19,459
+261% +$16.4K
CGAU
3863
Centerra Gold
CGAU
$4.24B
$16.6K ﹤0.01%
2,474
+2,438
+6,772% +$16K
RDW icon
3864
Redwire
RDW
$3.38B
$16.6K ﹤0.01%
2,309
-164
-7% -$789
RSSS icon
3865
Research Solutions
RSSS
$70.9M
$16.5K ﹤0.01%
6,468
+5,469
+547% +$15.5K
IAI icon
3866
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
$16.4K ﹤0.01%
140
– –
COYA icon
3867
Coya Therapeutics
COYA
$113M
$16.3K ﹤0.01%
+2,687
New +$21.6K
ALGS icon
3868
Aligos Therapeutics
ALGS
$45.5M
$16.3K ﹤0.01%
1,859
+1,538
+479% +$27K
ASNS
3869
DELISTED
ACTELIS NETWORKS INC
ASNS
$16.3K ﹤0.01%
704
-218
-24% -$2.13K
LUCD icon
3870
Lucid Diagnostics
LUCD
$183M
$16.2K ﹤0.01%
19,798
-175
-0.9% -$148
SU icon
3871
Suncor Energy
SU
$74B
$16.2K ﹤0.01%
426
-24,214
-98% -$936K
VCSH icon
3872
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$16.2K ﹤0.01%
210
-3,664
-95% -$282K
KT icon
3873
KT
KT
$8.83B
$16.2K ﹤0.01%
1,187
-3,251
-73% -$42.9K
SLS icon
3874
SELLAS Life Sciences
SLS
$2.17B
$16.2K ﹤0.01%
13,631
-7,094
-34% -$9.65K
BEAT icon
3875
Heartbeam
BEAT
$32.6M
$16.2K ﹤0.01%
6,310
+3,337
+112% +$7.54K
153 154
155
156 157

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.